CMZ-371

N/A

Report date: 2024/08/28 16:26:46

Base Information

Drug NameCMZ-371
Drug Alias NameCMZ371CMZ-371
ClassificationBiologics
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsGlucose-Dependent Insulinotropic Polypeptide Receptor agonists
TargetsGlucagon-like peptide 1 receptorGlucose-Dependent Insulinotropic Polypeptide Receptor
Therapy Area/IndicationsObesityDiabetes MellitusLiver Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesThe Calibr-Skaggs Institute for Innovative Medicines
China Registration ClassN/A

Develop Information

Active CompaniesThe Calibr-Skaggs Institute for Innovative Medicines
Inactive CompaniesN/A
Active IndicationsObesityDiabetes MellitusLiver Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A